Oral Anticoagulation Therapy

Part I. Introduction

1. Introduction
Kathryn Kiser

Part II. Atrial Fibrillation

2. CHA2DS2-VASc and HAS-BLED Risk Stratification Tools
Lea E. Pena

3. Male with Priority of Ischemic Stroke Reduction
David Parra, Augustus Hough

4. Choosing an Anticoagulant in an Elderly Patient
Jena I. Burkhart

5. Patient with Prior History of GI Hemorrhage
Michael Brenner, David Parra

6. Patients with a History of Intracranial Hemorrhage
Jordan D. Long, Douglas C. Anderson

7. Concerns with Anticoagulant Adherence
David Parra, Michael Brenner

8. Oral Anticoagulants in Stable Moderate Chronic Kidney Disease
James C. Lee

9. Oral Anticoagulants in Severe Renal Dysfunction
Jennifer Babin

10. Oral Anticoagulants in Patients with Variable Renal Function
James C. Lee

11. Patient with Concomitant Stable Coronary Artery Disease
Michael Brenner, Augustus Hough

12. Patient with Concomitant Acute Venous Thromboembolism
Lea E. Pena

13. Patient with Concomitant Mitral Valve Stenosis
Augustus Hough, Michael Brenner

14. Patient with Concomitant Aortic Valve Stenosis
Augustus Hough, David Parra

Part III. Warfarin Management

15. Best Practice for Switching Stable Warfarin Patients
Dave L. Dixon

16. Patient-Centered Strategies for Improving Warfarin Management
James C. Lee

Part IV. Venous Thromboembolism (VTE)

17. Provoked Versus Unprovoked Venous Thromboembolism
Jasmine M. Pittman

18. Venous Thromboembolism (VTE) Prophylaxis in Hip and Knee Replacement Surgery
Mary G. Amato, Danielle Carter

19. Venous Thromboembolism (VTE) Prophylaxis in the Intensive Care Unit (ICU)
Dillon Elliott

20. VTE and Recent Drug Eluting Stent (DES) Placement
Wendy M. Gabriel

21. Acute VTE in a Patient with Moderate Chronic Kidney Disease
Brenda Pahl, Douglas Anderson

22. Oral Anticoagulation and Duration in Recurrent Venous Thromboembolism (VTE)
Regina Arellano

23. Pulmonary Embolism (PE) with Thrombolytic Therapy
Justin M. Schmidt

Part V. Acute Coronary Syndrome (ACS)

24. Patient on Oral Anticoagulant Presenting with ACS
Craig J. Beavers

25. Oral Anticoagulant Therapy Post-Percutaneous Coronary Intervention
Craig J. Beavers

26. ST-Segment Elevation Myocardial Infarction (Lytic Candidate) on Oral Anticoagulant
Craig J. Beavers

27. ACS with Bypass Surgery
Craig J. Beavers

Part VI. Drug Interactions

28. Anticoagulant Drug-Drug Interactions with CYP 3A4 Inhibitors
Lea E. Pena

29. Significance of P-glycoprotein (P-gp) Drug-Drug Interactions
Dave L. Dixon

30. Considerations with Pharmacodynamic Drug-Drug Interactions
Jill S. Borchert

31. Management of Direct Oral Anticoagulants with Mixed P-gp/3A4 Drug-Drug Interactions
Kathryn Wdowiarz

32. Pharmacokinetic Drug-Drug Interactions with Warfarin
Rachel C. Ieuter

Part VII. Special Populations

33. Chronic Pain Management with Anticoagulation
Leah Sera

34. Anticoagulation Management in Atrial Fibrillation Catheter Ablation
Brian Cryder

35. Anticoagulation Management Considerations for Mechanical Valves
Denise M. Kolanczyk

36. Management of Antiphospholipid Antibody Syndrome
Margaret A. Felczak

37. Venous Thromboembolism and Pregnancy
Erika L. Hellenbart

38. Venous Thromboembolism in Active Malignancy
Margaret A. Felczak

39. Anticoagulation Management in Patients Undergoing Gastric Bypass Procedures
Brian Cryder

40. Patient Presenting with Minor Bleeding
Daniel M. Witt

41. Patient Presenting with Major, Life-Threatening Bleeding
Daniel M. Witt

42. Overdose of Dabigatran
Alicia Potter DeFalco

Keywords: Medicine & Public Health, Cardiology